Key Takeaway: Profound's innovative TULSA-PRO technology was prominently featured at AUA2022. A semi-live procedure was conducted by Dr. Kenneth A. Goldberg from UT Southwestern during the plenary session. This event showcased the advancements in prostate treatment and highlighted the technology's potential impact on patient care.
Price reaction · baseline $8.5 (2024-02-16 close) · 10 other PROF headline(s) in the window, move may be shared
day 0 close · peak
-2.7%
Market Sentiment Analysis
POSITIVE FACTORS
Highlighting of groundbreaking technology
Engagement in a prominent medical meeting
Live demonstration by a reputable doctor
Full Press Release Details
Activities Highlighting Profound’s Ground-Breaking Technology Included a Semi-Live TULSA Procedure Performed by UT Southwestern’s Dr. Kenneth A. Goldberg During Meeting’s Plenary Session Activities Highlighting Profound’s Ground-Breaking Technology Included a Semi-Live TULSA Procedure Performed by UT Southwestern’s Dr. Kenneth A. Goldberg During Meeting’s Plenary Session
Frequently Asked Questions
What is TULSA-PRO technology?
TULSA-PRO is an innovative technology developed by Profound for prostate treatment.
Who performed the TULSA procedure at AUA2022?
The semi-live TULSA procedure was performed by Dr. Kenneth A. Goldberg.
Where was the TULSA-PRO showcased?
TULSA-PRO was showcased at the AUA2022 meeting during a plenary session.
What is the significance of AUA2022?
AUA2022 is a prominent medical meeting focusing on advancements in urology.